Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease


Hacohen Y., YiWong Y., Lechner C., Jurynczyk M., Wright S., KONUŞKAN B. , ...More

JAMA NEUROLOGY, vol.75, no.4, pp.478-487, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.1001/jamaneurol.2017.4601
  • Title of Journal : JAMA NEUROLOGY
  • Page Numbers: pp.478-487

Abstract

IMPORTANCE Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently identified in a range of demyelinating disorders in adults and children. Current therapeutic strategies are largely center specific, and no treatments have been formally evaluated.